Evaluation and Management of Hand Numbness
Hand numbness requires systematic evaluation starting with clinical history to identify the distribution pattern (stocking-glove vs. nerve-specific), associated symptoms (tingling, pain, weakness), and potential underlying causes including diabetes, chemotherapy exposure, nerve compression, alcohol use, toxin exposure, nutritional deficiencies, or occupational vibration exposure. 1
Initial Clinical Assessment
Key History Elements
Focus your history on:
- Distribution pattern: Symmetric stocking-glove distribution suggests polyneuropathy, while symptoms confined to the first three digits (thumb, index, middle finger) on the palmar surface without dorsal hand or little finger involvement suggests carpal tunnel syndrome 2
- Temporal pattern: Progressive vs. acute onset, nocturnal exacerbation (typical of neuropathy) 3
- Associated symptoms: Tingling precedes numbness, which precedes pain in most peripheral neuropathies 4
- Exposures: Chemotherapy (particularly taxanes, oxaliplatin, paclitaxel), diabetes, alcohol, occupational vibration tools 4, 1, 5
- Asymmetry is a red flag: Symmetric symptoms are typical of polyneuropathy; asymmetric presentation requires investigation for alternative etiologies 3
Physical Examination Specifics
Perform:
- Sensory testing: Two-point discrimination and 30 Hz vibration perception are most frequently abnormal in early neuropathy 5
- Motor examination: Check for distal weakness or atrophy (indicates advanced disease) 1
- Provocative tests: Phalen's and Tinel's tests if carpal tunnel syndrome suspected 2
- Vascular examination: Exclude peripheral vascular disease 3
Diagnostic Workup
Initial Laboratory Testing
Order these tests first to identify treatable causes 1:
- Complete blood count
- Comprehensive metabolic profile
- Fasting blood glucose (diabetes is a leading cause)
- Vitamin B12 level (nutritional deficiency)
- Thyroid-stimulating hormone
- Serum protein electrophoresis with immunofixation
When to Use Electrodiagnostic Studies
Nerve conduction studies and EMG are not routinely necessary for diagnosis but should be considered to 4, 3:
- Exclude entrapment syndromes (particularly if symptoms suggest median nerve distribution)
- Differentiate axonal from demyelinating disease
- Confirm diagnosis when clinical picture is unclear
Important caveat: In chemotherapy-induced peripheral neuropathy (CIPN), diagnosis is primarily clinical—if a patient on neurotoxic chemotherapy develops new numbness/tingling in hands/feet without alternative explanation, the diagnosis is established 4
Management by Etiology
For Diabetic Peripheral Neuropathy
- Optimize glycemic control (primary intervention) 3
- For painful symptoms: Consider duloxetine or tricyclic antidepressants 3
- Assess using validated scales (11-point Likert scale: 0=no pain to 10=worst pain) 3
For Chemotherapy-Induced Peripheral Neuropathy
Treatment patterns differ by agent 4:
- Oxaliplatin: Symptoms worse in upper extremities during treatment, exhibit "coasting phenomenon" (worsen 2-3 months post-treatment before improving), hand symptoms improve faster than feet
- Paclitaxel: Symptoms worse in lower extremities during treatment, improve over several months post-treatment
For painful CIPN: Duloxetine is the only agent with moderate-strength recommendation 4
No recommendation can be made for exercise, acupuncture, scrambler therapy, gabapentin/pregabalin, topical compounds, or oral cannabinoids outside clinical trials due to insufficient evidence 4
For Carpal Tunnel Syndrome
When symptoms involve the palmar surface of the first three digits but not the dorsum or little finger, and Phalen's/Tinel's tests are positive 2:
- Consider nerve conduction studies to confirm
- Treat with splinting, activity modification, or surgical decompression based on severity
For Idiopathic Cases
25-46% of peripheral neuropathy cases remain idiopathic after comprehensive workup 1. In these cases:
- Focus on symptomatic management with gabapentinoids or antidepressants for neuropathic pain
- Monitor for progression
- Consider neurology referral for specialized testing (specific antibody assays, nerve biopsy)
Critical Pitfalls to Avoid
Don't assume "osteochondrosis" or spinal disease: Many patients with tunnel syndromes are misdiagnosed with cervical spine pathology 6
Don't overlook occupational exposures: Vibration tool exposure causes diffuse distal neuropathy that can mimic or coexist with carpal tunnel syndrome 5
Don't order extensive testing before basic labs: Start with the initial laboratory panel above—it identifies most treatable causes 1
Don't expect nerve conduction studies to correlate with symptom severity in vibration-exposed workers: Quantitative sensory testing and functional motor assessment are more useful 5